Bansi Desai
Stock Analyst at J.P. Morgan
(2.60)
# 2,989
Out of 4,670 analysts
72
Total ratings
45.7%
Success rate
3.2%
Average return
Main Sectors:
Stocks Rated by Bansi Desai
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Hold | ₹5,900 → ₹6,100 | ₹5,400 | +12.96% | 6 | Aug 17, 2026 | |
| NSE: ZYDUSLIFE Zydus Lifesciences Limited | Maintained: Hold | ₹1,050 → ₹1,240 | ₹1,120 | +10.71% | 5 | Aug 12, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Maintained: Buy | ₹1,120 → ₹1,180 | ₹907.10 | +30.08% | 6 | Aug 10, 2026 | |
| NSE: LUPIN Lupin Limited | Maintained: Hold | ₹2,600 → ₹2,700 | ₹2,202 | +22.63% | 6 | Aug 10, 2026 | |
| NSE: DIVISLAB Divi's Laboratories Limited | Maintained: Buy | ₹7,400 → ₹9,100 | ₹8,597 | +5.85% | 3 | Aug 4, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Downgraded: Hold | ₹2,850 → ₹2,700 | ₹2,384 | +13.26% | 7 | Aug 4, 2026 | |
| NSE: CIPLA Cipla Limited | Maintained: Buy | ₹1,550 → ₹1,600 | ₹1,432 | +11.72% | 6 | Jul 28, 2026 | |
| NSE: ANTHEM Anthem Biosciences Limited | Maintained: Buy | ₹850.00 → ₹900.00 | ₹869.50 | +3.51% | 4 | Jul 23, 2026 | |
| NSE: BLUEJET Blue Jet Healthcare Limited | Maintained: Sell | ₹600.00 → ₹370.00 | ₹596.15 | -37.94% | 4 | May 27, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Maintained: Sell | ₹1,090 → ₹1,150 | ₹1,175 | n/a | 4 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹34,500 → ₹37,000 | ₹26,230 | n/a | 5 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,350 → ₹1,550 | ₹1,863 | n/a | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,240 → ₹1,480 | ₹1,410 | n/a | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,030 → ₹1,970 | ₹1,902 | n/a | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,700 → ₹1,840 | ₹1,433 | n/a | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,390 → ₹1,325 | ₹1,000 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹8,800 | ₹8,693 | n/a | 1 | Feb 12, 2025 |
Alkem Laboratories Limited
Aug 17, 2026
Maintained: Hold
Price Target: ₹5,900 → ₹6,100
Current: ₹5,400
Upside: +12.96%
Zydus Lifesciences Limited
Aug 12, 2026
Maintained: Hold
Price Target: ₹1,050 → ₹1,240
Current: ₹1,120
Upside: +10.71%
Fortis Healthcare Limited
Aug 10, 2026
Maintained: Buy
Price Target: ₹1,120 → ₹1,180
Current: ₹907.10
Upside: +30.08%
Lupin Limited
Aug 10, 2026
Maintained: Hold
Price Target: ₹2,600 → ₹2,700
Current: ₹2,202
Upside: +22.63%
Divi's Laboratories Limited
Aug 4, 2026
Maintained: Buy
Price Target: ₹7,400 → ₹9,100
Current: ₹8,597
Upside: +5.85%
Mankind Pharma Limited
Aug 4, 2026
Downgraded: Hold
Price Target: ₹2,850 → ₹2,700
Current: ₹2,384
Upside: +13.26%
Cipla Limited
Jul 28, 2026
Maintained: Buy
Price Target: ₹1,550 → ₹1,600
Current: ₹1,432
Upside: +11.72%
Anthem Biosciences Limited
Jul 23, 2026
Maintained: Buy
Price Target: ₹850.00 → ₹900.00
Current: ₹869.50
Upside: +3.51%
Blue Jet Healthcare Limited
May 27, 2026
Maintained: Sell
Price Target: ₹600.00 → ₹370.00
Current: ₹596.15
Upside: -37.94%
Dr. Reddy's Laboratories Limited
Aug 19, 2025
Maintained: Sell
Price Target: ₹1,090 → ₹1,150
Current: ₹1,175
Upside: n/a
Aug 15, 2025
Maintained: Buy
Price Target: ₹34,500 → ₹37,000
Current: ₹26,230
Upside: n/a
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,350 → ₹1,550
Current: ₹1,863
Upside: n/a
Aug 11, 2025
Maintained: Hold
Price Target: ₹1,240 → ₹1,480
Current: ₹1,410
Upside: n/a
Aug 1, 2025
Maintained: Buy
Price Target: ₹2,030 → ₹1,970
Current: ₹1,902
Upside: n/a
Jul 29, 2025
Maintained: Buy
Price Target: ₹1,700 → ₹1,840
Current: ₹1,433
Upside: n/a
May 22, 2025
Maintained: Buy
Price Target: ₹1,390 → ₹1,325
Current: ₹1,000
Upside: n/a
Feb 12, 2025
Maintained: Buy
Price Target: ₹8,800
Current: ₹8,693
Upside: n/a